7

Oceanaa Biotek industries

790160

Tapetide Score

Data-driven rating, 0–100. How it works →

Key Insights

Strengths

3
  • Company has reduced debt.
  • Company is almost debt free.
  • Stock is trading at 0.11 times its book value

Weaknesses

3
  • Company has low interest coverage ratio.
  • The company has delivered a poor sales growth of -11.2% over past five years.
  • Company has a low return on equity of -1.79% over last 3 years.

Growth Rate

Revenue Growth
32% higher than 3Y
Net Income Growth
93% higher than 3Y

Quarterly Results

Particulars Dec 2017Mar 2018Jun 2018Sep 2018Dec 2018Mar 2019Jun 2019Sep 2019Dec 2019Mar 2020Jun 2020Sep 2020Dec 2020
Sales
15.45
21.71
11.02
14.02
8.02
3.24
4.55
5.24
3.28
12.58
4.53
3.54
0.9
Expenses
10.35
11.12
9.47
10.86
7.05
26.86
2.82
3.3
1.8
13.01
2.62
2.84
1.88
Operating Profit
5.1
10.59
1.55
3.16
0.97
-23.62
1.73
1.94
1.48
-0.43
1.91
0.7
-0.98
OPM %
33.01%
48.78%
14.07%
22.54%
12.09%
-729.01%
38.02%
37.02%
45.12%
-3.42%
42.16%
19.77%
-108.89%
Other Income
0.02
0
0
0
0
0
0
0
0
0.03
0
0
0
Interest
0.03
0.03
0.03
0.03
0.03
0.02
0.02
0.02
0.02
0.02
0.02
0.01
0.01
Depreciation
0.85
0.98
0.79
0.79
0.79
0.14
0.54
0.54
0.54
0.54
0.46
0.46
0.46
PBT
4.24
9.58
0.73
2.34
0.15
-23.78
1.17
1.38
0.92
-0.96
1.43
0.23
-1.45
Tax %
10.85%
48.12%
-46.58%
27.35%
6.67%
0%
-0.85%
5.07%
-20.65%
47.92%
16.08%
17.39%
0%
Net Profit
3.78
4.97
1.08
1.69
0.14
-23.78
1.18
1.3
1.1
-1.41
1.21
0.2
-1.45
EPS in Rs
2.79
3.66
0.8
1.25
0.1
-17.53
0.87
0.96
0.81
-1.04
0.89
0.15
-1.07
Figures in ₹ Crores

Profit & Loss

Particulars Mar 2009Mar 2010Mar 2011Mar 2012Mar 2013Mar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020TTM
Sales
0
0
0
0.01
0.34
6.7
46.39
32.12
36.45
60.44
36.28
25.66
21.55
Expenses
0.02
0.02
0.02
0.02
0.3
5.95
44.28
26.98
31.05
39.42
48.93
20.93
20.35
Operating Profit
-0.02
-0.02
-0.02
-0.01
0.04
0.75
2.11
5.14
5.4
21.02
-12.65
4.73
1.2
OPM %
-100%
11.76%
11.19%
4.55%
16%
14.81%
34.78%
-34.87%
18.43%
5.57%
Other Income
0
0
0
0
0
-0.16
-0.16
-0.15
0.04
0.08
-5.24
0.03
0.03
Interest
0
0
0
0
0
0.01
0.06
0.11
0.04
0.72
0.17
0.1
0.06
Depreciation
0
0
0
0
0
0.01
0.63
1.34
1.1
3.46
2.5
2.17
1.92
PBT
-0.02
-0.02
-0.02
-0.01
0.04
0.57
1.26
3.54
4.3
16.92
-20.56
2.49
-0.75
Tax %
0%
0%
0%
0%
25%
40.35%
36.51%
38.14%
36.05%
35.28%
-2.48%
11.24%
Net Profit
-0.02
-0.02
-0.02
-0.01
0.03
0.35
0.81
2.18
2.75
10.94
-20.05
2.22
-1.45
EPS in Rs
0.06
0.39
0.79
2.14
2.7
8.06
-14.78
1.64
-1.07
Div. Payout %
0%
0%
0%
0%
0%
0%
0%
16.51%
22.25%
18.61%
0%
0%
Figures in ₹ Crores

Balance Sheet

Particulars Mar 2009Mar 2010Mar 2011Mar 2012Mar 2013Mar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Sep 2020
Equity Capital
0.01
0.01
0.01
0.01
3.12
5.22
6
6
10.2
13.57
13.57
13.57
13.57
Reserves
-0.03
-0.05
-0.07
-0.07
-0.05
0.29
4.22
5.97
4.89
31.68
11.7
13.92
15.21
Borrowings
0
0
0
0
0
0
0.12
0.07
0.04
1.28
1.03
0.75
0.61
Other Liabilities
0.08
0.08
0.09
0.06
0.26
4.18
3.08
7.41
7.18
13.89
12.89
12.79
13.75
Total Liabilities
0.06
0.04
0.03
0
3.33
9.69
13.42
19.45
22.31
60.42
39.19
41.03
43.14
Fixed Assets
0
0
0
0
0.04
0.03
7.48
6.76
5.81
24.38
16.66
21
13.6
CWIP
0
0
0
0
0
0
0
0
0
0
0
0
6.5
Investments
0
0
0
0
0
0
0
0.05
0
0
0
0
0
Other Assets
0.06
0.04
0.03
0
3.29
9.66
5.94
12.64
16.5
36.04
22.53
20.03
23.04
Total Assets
0.06
0.04
0.03
0
3.33
9.69
13.42
19.45
22.31
60.42
39.19
41.03
43.14
Figures in ₹ Crores

Cash Flow

Particulars Mar 2009Mar 2010Mar 2011Mar 2012Mar 2013Mar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020
Operating
0.01
0.14
1.98
1.05
0.52
1.71
-5.34
6.79
Investing
0
-0.04
-8.08
-0.67
-0.15
-22.03
5.22
-6.49
Financing
0
0
4.02
-0.04
-0.47
20.45
-0.25
-0.27
Net Cash Flow
0.01
0.1
-2.08
0.34
-0.1
0.13
-0.37
0.02
Free Cash Flow
0.01
0.1
-6.1
0.43
0.37
-20.33
-0.13
0.29
CFO/OP
-100
350
113
49
40
34
42
144
Figures in ₹ Crores

Ratios

Particulars Mar 2009Mar 2010Mar 2011Mar 2012Mar 2013Mar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020
Debtor Days
0
10.74
230
39.97
28.98
48.67
65.34
107
74.96
Inventory Days
776
0
0
93.17
85.06
78.69
6.1
26.25
Days Payable
137
99.47
74.66
44.61
42.34
124
Cash Conversion Cycle
0
649
230
39.97
22.67
59.06
99.42
70.5
-23.02
Working Capital Days
-2,190
3,135
182
21.4
53.07
90.72
136
96.18
105
ROCE %
2.66%
17.25%
18.68%
33.96%
31.95%
57.22%
-41.58%
9.5%

Insights

Beta

AI-extracted from concalls & annual reports · figures as reported, with sources

Log in to view Oceanaa Biotek industries insights

55 extracted metrics + investor summaries across FY09–FY20.

Log in — free

Shareholding Pattern

Public60.91%Promot.39.09%As ofDec 2020

Documents

Frequently Asked Questions about Oceanaa Biotek industries

What does Oceanaa Biotek industries Ltd do?
Oceanaa Biotek Industries Limited is a specialized food testing company. The Company is engaged in the production and trading of shrimp seeds. It is primarily focused on rearing of prawn seeds.
Which sector does Oceanaa Biotek industries Ltd belong to?
Oceanaa Biotek industries Ltd is classified under the Fast Moving Consumer Goods sector, in the Food Products industry.

Company Information

Oceanaa Biotek Industries Limited is a specialized food testing company. The Company is engaged in the production and trading of shrimp seeds. It is primarily focused on rearing of prawn seeds.

Listed 2014-04-03
Face Value ₹ 10

For AI agents and developers

Reading this as an AI agent, LLM or automated pipeline? Every page on Tapetide is also published as clean Markdown — no navigation, no scripts, just the data. Fetch https://tapetide.com/stocks/790160.md for Oceanaa Biotek industries Ltd: company profile, latest price, key fundamentals, the Tapetide Score, growth rates, quarterly and annual financial statements, shareholding pattern, technical indicators, analyst ratings and exchange filings.

Append .md to any Tapetide URL for the same treatment. A full index of what we publish is at /llms.txt and /llms-full.txt. For live, structured queries instead of documents, use our MCP server.

Explore More